Cosmetic or Drug: Claims That Pull You Out of MoCRA
How specific marketing claims reclassify a US cosmetic as an OTC drug, with the tighter substantiation rules that follow.
Somewhere between "moisturizes skin" and "treats eczema" there's a line, and crossing it changes which federal framework your product lives under. This trips up more indie brands than any ingredient question, because it's not about what's in the bottle. It's about what you say the bottle does.
The classification hinges on intended use
Under US law, whether something is a cosmetic or a drug comes down to intended use, and intended use is largely established by your labeling and marketing claims. A product can have an identical formula to another product and land in a completely different regulatory bucket depending on what the label promises. This is the same logic that applies to soap: an alkali salt of fatty acids sold purely on a cleansing claim can be treated as true soap, but the moment that same bar claims to moisturize, soften, or fight acne, it's a cosmetic. Push the claim further into treating a condition, and it becomes a drug.
MoCRA, the Modernization of Cosmetics Regulation Act from 2022, governs facility registration, product listing, a named responsible person, and safety substantiation for cosmetics. None of that framework applies to a product once it's functioning as a drug. Drugs get regulated under a completely separate and more demanding system, generally requiring compliance as an over-the-counter drug rather than listing as a cosmetic.
Claims that commonly cross the line
Here's where brands get caught off guard, often because the claim felt like normal beauty marketing:
- "Treats acne" or "clears acne" instead of "reduces the appearance of blemishes." Acne treatment is a drug claim.
- "Reduces dandruff" or "eliminates dandruff" rather than describing a cosmetic scalp-conditioning benefit. Anti-dandruff products are typically regulated as drugs.
- "Blocks UV rays" or any SPF number. Sunscreen is regulated as an OTC drug, not a cosmetic, full stop. There's no cosmetic-side version of an SPF claim.
- "Stops sweating" or "reduces perspiration" as opposed to a cosmetic deodorizing claim. Antiperspirants are drugs.
- "Whitens teeth by killing bacteria" or fluoride claims. Fluoride toothpaste sits in drug territory.
- "Heals," "cures," "treats a medical condition," or references to a diagnosed disease in almost any product category. This is the broadest trap, because it's tempting language for a brand trying to sound effective.
Why this matters more than it seems
It's tempting to treat this as a wording technicality you can fix later. It isn't. If your product's claims put it in drug territory, the whole compliance pathway changes:
- You're no longer working within MoCRA's registration and listing framework as a cosmetic.
- You're likely looking at OTC drug monograph compliance or a new drug application pathway, both of which carry far heavier testing, manufacturing, and review requirements than a cosmetic filing.
- Your safety substantiation standard changes from cosmetic-level to drug-level, which is a different order of documentation and evidence.
- Retailers and marketplaces that accept cosmetic listings may reject the product outright once they see drug-coded language, regardless of your actual regulatory status.
A practical claims checklist before you finalize copy
| If your draft claim says... | Consider instead | Why |
|---|---|---|
| Treats, cures, heals | Improves the appearance of, helps reduce the look of | Keeps the claim cosmetic, not therapeutic |
| Kills bacteria/germs | Cleanses, refreshes | Antimicrobial claims often trigger drug or antiseptic rules |
| Reduces inflammation | Soothes, calms the look of skin | Inflammation is a medical term implying treatment |
| Anti-aging + specific medical term | Reduces the appearance of fine lines | Appearance language stays cosmetic; medical terms don't |
| Blocks sun/UV | Not usable for a cosmetic at all | Sunscreen claims require OTC drug status regardless of formula |
Where this leaves a maker
If your product is a genuine cosmetic and your claims stay in appearance-and-look territory, MoCRA's registration, listing, and safety substantiation requirements are the framework you're working within, and some small businesses are even exempt from the registration and listing pieces. The moment your marketing team wants a punchier claim that implies treating a condition, it's worth pausing and asking whether that single sentence is worth reclassifying the entire product.
Before you lock in label copy, it's worth running your ingredient list and claims past someone who can flag the borderline cases early. That's part of what Cosmetic Comply's review step is for: matching ingredients and screening against restricted lists so the claims side isn't the only thing standing between you and a clean filing.
Send your ingredients and we take it from here
A short intake form is all it takes to start. Every ingredient gets checked against your market's prohibited and restricted lists, then we file your notification and hand you a number you can track.
Start a filingKeep reading
Common Cosmetics Direct Submission Errors to Avoid
A troubleshooting list of the frequent mistakes that cause rejected or inaccurate MoCRA product listings, and how to fix each one.
Fragrance Allergen Labeling and the April 12 2026 List
What Canada's List 1 fragrance allergen disclosure means for your CNF and label starting April 12, 2026, and how to check your formula now.
How to List Multiple Products Under One Facility
A practical workflow for listing a growing catalog with the FDA under MoCRA without duplicating work or losing track of facility numbers.
Private Label Brands and Who Owns MoCRA Compliance
Working through a private label scenario to pin down who is legally the responsible person under MoCRA when reselling a stock formula.